Added: 2 years ago
From: Kshivets002
Views: 10,215
Sort by time | Sort by thread (beta)

Link to this comment:

Share to:

All Comments (15)

Sign In or Sign Up now to post a comment!
  • Comment removed

  • @muellerk234 Esophageal and cardioesophageal cancer patients are living after radical (complete R0) esophagogastrectomies with lymphadenectomy till 10-20 years. Without surgery - several weeks or months. Every student knows this information.

  • How many years of reflux did this patient have ?

    Did the patient have B.E. ?

  • @RETIREMESOON Good question. As I impose manual esophagogastro-or esophagojejunoanastomosis typed "inkwell" a reflux-esophagitis and Barret's esophagus does not happen. One my familiar surgeon who wrote the dissertation on this theme, specially was engaged in diagnosis of esophagitis. He did not find any case of BE and esophagitis at my patients while after stepler and other kinds of anastomosis there are marked about 20-30% reflux-esophagitis and 5-7% BE.

  • @Kshivets002 Doctor I thank You for your reply to my previous question regarding BE. I am currently addressing my reflux issue of the last 4 years.

    I am using weight loss and medication and medical education.

    The problem in North America seems to be that TV commercials give you the idea that simple indigestion is___ NOT___ a serious medical issue.

    Our town has recently lost a 37 year old male and a 49 year old male to Esophagial cancer and I hear that this cancer is 87 % fatal.

  • @RETIREMESOON Esophageal & cardioesophageal cancer is extremely aggressive tumors. Unique chance to survive is radical operation (5-year survival reaches 50%). But these procedures are considered in surgery as the most difficult and dangerous. For example, heart transplantation now is about 1 hour surgery, esophagogastrectomy (Lewis, Garlock) is of 4-8 hours. In the USA experienced esophageal surgeons are in tens and hundreds times less than transplantologists.

  • very strong surgeon

  • As regards the early cancer that it is all quite clear. For these patients only radical surgery is absolutely sufficient and adjuvant treatment is no need. From this it follows the paramount importance of screening and early detection of esophageal and cardioesophageal cancer.

  • Here following benefits should be considered: possibility of total elimination of residual hidden micrometastases; 2) surgery and chemoradiotherapy can result immunosuppressive state, which can be improved by immunotherapy; 3) radical operated patients with stage IIB-IVA are thought to be potentially good candidates for adjuvant chemoimmunoradiotherapy as majority of these patients would be expected to have cancer progressing.

  • Personally I prefer to appoint adjuvant chemoimmunoradiotherapy after surgery to all patients with lymph node metastasises and local advanced cancer.

  • What about adjuvant chemotherapy for esophageal cancer patients?

  • Perfectly!

  • Extraordinary surgeon!

  • Yes, master!

  • Unique and simultaneously universal surgeon!

Loading...
Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more